Dermatologicals in Argentina
As consumers adjust to normality after the third wave outbreak of COVID-19 in Argentina, dermatologicals are showing an outstanding recovery in 2022. Previously dynamic categories, such as antiparasitics/lice (head and body) treatments, saw retail volume sales plummet in 2021 as a consequence of COVID-19 pandemic, which abruptly disrupted school life and children’s activities in general. A return to normal schooling and play activities, and pre-pandemic lifestyles in general, increase the risk o...
Euromonitor International's Dermatologicals in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Dermatologicals in Argentina
- Euromonitor International
- September 2022
- List Of Contents And Tables
- DERMATOLOGICALS IN ARGENTINA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Sales rebound in 2022 as consumers return to normal lifestyles
- New product developments help to fuel ongoing growth
- Topical germicidals/antiseptics see boost from a return to more active, out-of-home activities
- PROSPECTS AND OPPORTUNITIES
- Further recuperation expected for sales of dermatologicals, supported by the return of in-store displays
- New product development is expected to increase demand of dermatologicals during the forecast period
- Online sales are predicted to continue improving in the coming years
- CATEGORY DATA
- Table 1 Sales of Dermatologicals by Category: Value 2017-2022
- Table 2 Sales of Dermatologicals by Category: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Dermatologicals: % Value 2018-2022
- Table 4 LBN Brand Shares of Dermatologicals: % Value 2019-2022
- Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2019-2022
- Table 6 Forecast Sales of Dermatologicals by Category: Value 2022-2027
- Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
- CONSUMER HEALTH IN ARGENTINA
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 9 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 10 Sales of Consumer Health by Category: Value 2017-2022
- Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources